Tissue Engineering Market Report 2026

The tissue engineering market size has grown rapidly in recent years. It will grow from $17.33 billion in 2025 to $19.78 billion in 2026 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to advancements in biomaterial science, expansion of academic tissue engineering research, increasing demand for organ repair solutions, availability of biocompatible scaffold materials, growth of clinical regenerative studies.

The tissue engineering market size is expected to see rapid growth in the next few years. It will grow to $33.31 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to increasing investments in regenerative medicine, rising adoption of personalized tissue therapies, expansion of clinical translation of engineered tissues, growing integration of ai-driven tissue design, increasing demand for advanced organ replacement solutions. Major trends in the forecast period include increasing adoption of advanced scaffold materials, rising focus on regenerative medicine applications, growing integration of 3D bioprinting technologies, expansion of cell-based tissue therapies, enhanced emphasis on functional tissue restoration.

The rising prevalence of cardiovascular disorders is expected to drive the growth of the tissue engineering market in the coming years. Cardiovascular disorders, also referred to as cardiovascular diseases (CVD), are a group of medical conditions that affect the heart and blood vessels. Tissue engineering is applied in cardiovascular disorders to provide promising solutions for repairing and regenerating damaged cardiac and vascular tissues. For example, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, representing a 4% increase from 224.4 per 100,000 in 2023. Therefore, the rising prevalence of cardiovascular disorders is supporting the growth of the tissue engineering market.

Leading companies in the tissue engineering market are forming strategic partnerships and collaborations with start-ups and mid-sized companies to expand their products and services. Strategic collaborations and partnership agreements enable companies to broaden their existing product portfolios and extend their geographical reach. For instance, in June 2023, Regen Lab, a Swiss-based commercial-stage medical technology company specializing in research, development, registration, manufacturing, and commercialization of proprietary tissue engineering products, entered into a collaboration agreement with Long Island University (LIU) and Dassault Systèmes Group (3DS). Under the agreement, LIU and RegenLab USA will share resources to establish an industrial innovation accelerator, a new center of excellence dedicated to regenerative medicine and tissue engineering. Long Island University is a US-based university, and Dassault Systèmes Group is a France-based software corporation.

In January 2023, ReLive Biotechnologies, Ltd., a China-based therapeutic company, acquired Co.Don AG for an undisclosed sum. Through this acquisition, ReLive aims to accelerate its global expansion and strengthen its regenerative medicine pipeline by gaining established manufacturing capabilities and internationally recognized cartilage repair products, facilitating global commercialization. Co.Don AG is a Germany-based biotech company specializing in autologous cell therapies for the regenerative treatment of cartilage defects, a form of tissue engineering.

Major companies operating in the tissue engineering market are Medtronic plc, Zimmer Biomet, Organogenesis Holdings Inc., Integra LifeSciences, Stryker Corporation, DePuy Synthes Companies, RTI Surgical Inc., Vericel Corporation, Athersys Inc., Tissue Regenix Group plc, Xeltis AG, Prellis Biologics, Bit Bio, Be Biopharma Inc., TELA Bio Inc., Orthocell Limited, Organovo Holdings Inc., EpiBone, TissueLabs, CollPlant Biotechnologies Ltd., Osiris Therapeutics Inc.

North America was the largest region in the tissue engineering market in 2025. Asia-Pacific is expected to be the fastest-growing region in the tissue engineering market during the forecast period. The regions covered in the tissue engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tissue engineering market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the tissue engineering market by increasing costs of imported biomaterials, laboratory instruments, cell culture media, bioreactors, and advanced fabrication equipment. Research institutions and hospitals in North America and Europe are most affected due to reliance on specialized imported inputs, while Asia-Pacific faces higher costs in scaffold material sourcing. These tariffs are raising research and development expenses and slowing scale-up activities. However, they are also encouraging domestic biomaterial production, regional manufacturing of tissue engineering tools, and localized innovation ecosystems supporting long-term market growth.

The tissue engineering market research report is one of a series of new reports that provides tissue engineering market statistics, including tissue engineering industry global market size, regional shares, competitors with a tissue engineering market share, detailed tissue engineering market segments, market trends and opportunities, and any further data you may need to thrive in the tissue engineering industry. This tissue engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Tissue engineering is a branch of biomedical engineering that combines principles from biology and engineering to create 3-D tissue and cellular constructs both in vivo and in vitro by modifying cell growth conditions and utilizing appropriate cell isolates from donor tissue along with biocompatible scaffold materials. It employs a variety of techniques to restore, repair, maintain, and enhance tissue function by replacing or regenerating damaged tissue, thereby improving the overall functionality of the human body.

The primary types of tissue engineering include synthetic scaffold materials, biologically derived scaffold materials, and others. Synthetic scaffold materials are composed of synthetic polymers made from fibrous proteins that function as an extracellular matrix, promoting cellular response and influencing cell behavior in tissue engineering. These materials are applied across multiple fields, including orthopedics and musculoskeletal, neurology, cardiovascular, skin and integumentary, dental, and more, and are utilized by various end users such as hospitals, clinics, and ambulatory care facilities.

The tissue engineering market consists of sales of reparative cells, bioreactive molecules, such as cytokines, growth factors, biomaterials, and bioreactors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.